A court sided with Medtronic (NYSE:MDT), overturning a 2023 verdict ordering the medtech giant to pay a significant amount in a patent suit.

A U.S. appeals court on Friday overturned a jury's verdict that medical device maker Medtronic owes competitor Colibri $106.5 ...

On Friday, July 18, the Federal Circuit issued a precedential decision reversing the Central District of California’s denial ...

The Federal Circuit overturned a $106 Million verdict against Medtronic, ruling that Colibri was barred from claiming patent infringement.

US appeals court rules that rival medtech company Colibri Heart Valve could not assert infringement under doctrine of equivalents ...

In 2023, a jury found that Medtronic infringed on a patent for a heart valve replacement method developed by Colibri Heart Valve.

Colibri Real Estate vs. PrepAgent PrepAgent is well-known for its engaging exam prep tools, including flashcards, practice tests, and videos, but it lacks comprehensive pre-licensing courses.